• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FISHER & PAYKEL HEALTHCARE LTD OPTIFLOW + ADULT NASAL CANNULA; BTT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FISHER & PAYKEL HEALTHCARE LTD OPTIFLOW + ADULT NASAL CANNULA; BTT Back to Search Results
Model Number OPT944
Device Problem Material Split, Cut or Torn (4008)
Patient Problem Low Oxygen Saturation (2477)
Event Date 11/17/2022
Event Type  malfunction  
Event Description
A healthcare facility in edmonton reported, via a fisher and paykel healthcare field representative, that the tubing of an opt944 + adult nasal cannula was found torn during a patient turn.The patient's oxygen saturation did not drop below 91% spo2.The subject cannula was then replaced and there were no further reported patient consequences for the patient.
 
Manufacturer Narrative
Fisher & paykel healthcare is currently in the process of completing our investigation.We will provide a follow up report upon completion of our investigation.Product background: the opt944 optiflow + adult nasal cannula is a nasal cannula patient interface for delivery of humidified gases, including those who are receiving nasal high flow therapy.Optiflow + interfaces are designed for use with the aivo 2 series of humidification and may also be compatible with the fisher and paykel mr850 and 950 humidification system devices.Nhf therapy is intended for use with spontaneously breathing patients who would benefit from receiving high flow warmed and humidified gases nhf therapy should noit be used for life support purposes.And appropriate monitoring must be used at all times.
 
Manufacturer Narrative
(b)(4).Product background: the opt944 optiflow + adult nasal cannula is a nasal cannula patient interface for delivery of humidified respiratory gases, including those who are receiving nasal high flow therapy (nhf).Optiflow + interfaces are designed for use with the airvo 2 series of humidification devices and may also be compatible with the fisher and paykel mr850 and 950 humidification system devices.Nhf therapy is intended for use with spontaneously breathing patients who would benefit from receiving high flow warmed and humidified respiratory gases nhf therapy should not be used for life support purposes, and appropriate patient monitoring must be used at all times.The cannula consists of a lightweight delivery tube connected to a rigid plastic base and soft nasal prongs (nasal interface).This allows the device to be light weight and durable.The interface is held in place by a head strap and features a head strap clip which works in tandem with the tubing clip (attaches to the patient's clothing/bedding) to support the weight of the circuit and prevent the cannula being dislodged.Method: the complaint opt944 optiflow + adult nasal cannula was not returned to fisher & paykel healthcare (f&p) for evaluation and additional information such as the lot number could not be provided, as the healthcare facility had discarded the device and the packaging.Our investigation is based on the information provided by the customer, previous investigations of similar complaints, and our knowledge of the product.Results: the healthcare facility has stated that the opt944 optiflow + adult nasal cannula was found torn during a patient turn and the patient's oxygen saturation level did not drop below 91%.Further information requested from the healthcare facility confirmed that the tubing of the subject device was caught between the patient and bed rail and when the patient rolled onto their back, the tubing broke.Conclusion: without the return of the subject device for evaluation, our investigation was unable to determine the exact cause of the reported damage.Based on our knowledge of the product, the reported damage is likely to have been caused by the tubing being subjected to excessive force during a patient turn, while being caught between the patient and bed rail.F&p's manufacturing controls for the optiflow+ adult nasal cannula tubing include inspections during production for visual defects including cracks, tears, moulding defects, contamination, inclusions, discoloration and stretching or deformation.Any product that fails the visual inspection is rejected.The subject opt944 optiflow+ adult nasal cannula would have met the required specifications.The user instructions which accompany the opt944 optiflow + adult nasal cannula show in pictorial format the correct placement and fitting of the cannula, including ensuring the head strap clip and the tubing clip are appropriately attached.The user instructions also warn: - "ensure head strap clip is attached, to prevent cannula from being pulled out of the nares." - "cannula can become unattached if not used with the head strap clip." - "attach tubing clip to clothing/bedding to prevent cannula from pulling off face." - "appropriate patient monitoring must be used at all times.Failure to monitor the patient may result in loss of therapy, serious injury or death." - "do not crush or stretch tube, to prevent loss of therapy." - "failure to use the set-up described above can compromise performance and affect patient safety.".
 
Event Description
A healthcare facility in edmonton reported, via a fisher and paykel healthcare field representative, that the tubing of an opt944 + adult nasal cannula was found torn during a patient turn.The healthcare facility further reported that the tubing of the subject device had been caught between the patient and bed rail and when the patient rolled onto their back, the tubing broke.The patient's oxygen saturation did not drop below 91% spo2.The subject cannula was then replaced and there were no further reported patient consequences for the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLOW + ADULT NASAL CANNULA
Type of Device
BTT
Manufacturer (Section D)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland,
NZ 
Manufacturer (Section G)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland
Manufacturer Contact
faranak gomarooni
17400 laguna canyon road
suite 300
irvine, CA 92618
9494534002
MDR Report Key16040333
MDR Text Key306086478
Report Number9611451-2022-01239
Device Sequence Number1
Product Code BTT
Combination Product (y/n)Y
Reporter Country CodeCA
PMA/PMN Number
K162553
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberOPT944
Device Catalogue NumberOPT944
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received02/01/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-